Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
Internal Medicine Journal|January 11, 2025
Risk factors associated with 30-day mortality following COVID-19 infection in patients receiving kidney replacement therapy in Australia and New ZealandPeter Kolovos, Christopher E Davies, Feruza Kholmurodova, et al.Internal Medicine Journal|April 11, 2025
Glomerular disease registry and biobank: design and baseline resultsAndrew Jeyaruban, Bhadran Bose, Vincent W Lee, et al.BMJ Open|September 4, 2025
Quality of care for people with chronic kidney disease: a systematic review and meta-analysisDaniel Bekele Ketema, Hannah Wallace, Workagegnehu Hailu, et al.Diabetes, Obesity & Metabolism|January 9, 2025
Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trialAmanda Siriwardana, Luke Buizen, Min Jun, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 30, 2026
Prevalence Of CKD Among Adults in Africa: A Systematic Review and Meta-AnalysisCindy George, Ikechi G Okpechi, Dipuo D Motshwari, et al.Diabetes, Obesity & Metabolism|May 29, 2024
Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trialNavdeep Tangri, Thomas W Ferguson, Ryan J Bamforth, et al.Kidney International Reports|February 12, 2024
The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice DatasetMin Jun, James Wick, Brendon L Neuen, et al.Diabetes, Obesity & Metabolism|February 19, 2021
Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trialMin Jun, Katie Harris, Hiddo J L Heerspink, et al.Lancet (London, England)|March 18, 2015
Worldwide access to treatment for end-stage kidney disease: a systematic reviewThaminda Liyanage, Toshiharu Ninomiya, Vivekanand Jha, et al.Clinical Endocrinology|September 17, 2025
Mass Spectrometric Measurements of 11-Deoxycortisol, Androstenedione and Dehydroepiandrosterone Are Superior to Cortisol to Assess Selectivity of Non-Stimulated Adrenal Vein SamplingFrancesco Alessi, Christina Pamporaki, Mirko Peitzsch, et al.Pageof 6